|
Myeloid Neoplasia
Citations 111-120 of 176 total displayed.
|
Past content
(since Jan 2009):
|
Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias
- Jessica Koenigsmann, Cornelia Rudolph, Sandrine Sander, Olivia Kershaw, Achim D. Gruber, Lars Bullinger, Brigitte Schlegelberger, and Dirk Carstanjen
Blood 2009; 113: 4690-4701.
[Abstract]
[Full text]
[PDF]
Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia
- Kazuko Miyazaki, Norimasa Yamasaki, Hideaki Oda, Takeshi Kuwata, Yohei Kanno, Masaki Miyazaki, Yukiko Komeno, Jiro Kitaura, Zen-ichiro Honda, Søren Warming, Nancy A. Jenkins, Neal G. Copeland, Toshio Kitamura, Takuro Nakamura, and Hiroaki Honda
Blood 2009; 113: 4702-4710.
[Abstract]
[Full text]
[PDF]
The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course
- Constantine S. Tam, Lynne V. Abruzzo, Katherine I. Lin, Jorge Cortes, Alice Lynn, Michael J. Keating, Deborah A. Thomas, Sherry Pierce, Hagop Kantarjian, and Srdan Verstovsek
Blood 2009; 113: 4171-4178.
[Abstract]
[Full text]
[PDF]
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
- Gunnar Juliusson, Petar Antunovic, Åsa Derolf, Sören Lehmann, Lars Möllgård, Dick Stockelberg, Ulf Tidefelt, Anders Wahlin, and Martin Höglund
Blood 2009; 113: 4179-4187.
[Abstract]
[Full text]
[PDF]
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism
- Paola Secchiero, Elisabetta Melloni, Maria Grazia di Iasio, Mario Tiribelli, Erika Rimondi, Federica Corallini, Valter Gattei, and Giorgio Zauli
Blood 2009; 113: 4300-4308.
[Abstract]
[Full text]
[PDF]
Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis
- Gordon Chan, Demetrios Kalaitzidis, Tatiana Usenko, Jeffery L. Kutok, Wentian Yang, M. Golam Mohi, and Benjamin G. Neel
Blood 2009; 113: 4414-4424.
[Abstract]
[Full text]
[PDF]
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG
- Jan Braess, Karsten Spiekermann, Peter Staib, Andreas Grüneisen, Bernhard Wörmann, Wolf-Dieter Ludwig, Hubert Serve, Albrecht Reichle, Rudolf Peceny, Daniel Oruzio, Christoph Schmid, Xaver Schiel, Marcus Hentrich, Christina Sauerland, Michael Unterhalt, Michael Fiegl, Wolfgang Kern, Christian Buske, Stefan Bohlander, Achim Heinecke, Herrad Baurmann, Dietrich W. Beelen, Wolfgang E. Berdel, Thomas Büchner, and Wolfgang Hiddemann
Blood 2009; 113: 3903-3910.
[Abstract]
[Full text]
[PDF]
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
- Grace H. Ku, Richard H. White, Helen K. Chew, Danielle J. Harvey, Hong Zhou, and Ted Wun
Blood 2009; 113: 3911-3917.
[Abstract]
[Full text]
[PDF]
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response
- Keith W. Pratz, Jorge Cortes, Gail J. Roboz, Niranjan Rao, Omotayo Arowojolu, Adam Stine, Yukimasa Shiotsu, Aiko Shudo, Shiro Akinaga, Donald Small, Judith E. Karp, and Mark Levis
Blood 2009; 113: 3938-3946.
[Abstract]
[Full text]
[PDF]
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
- Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara, Shaw-Cheng Liu, Wee-Joo Chng, Kian-Ghee Tay, Lai-Fong Poon, Zhigang Xie, Senthilnathan Palaniyandi, Hanry Yu, Keith B. Glaser, Daniel H. Albert, Steven K. Davidsen, and Chien-Shing Chen
Blood 2009; 113: 4052-4062.
[Abstract]
[Full text]
[PDF]
|
|
